Uta C. Hoppe - Concepedia

Author

Uta C. Hoppe

Also Known As

C Reiter, D Hrncic, Hoppe, Ignacio Cruz Gonzalez, Karin Brandner, M Grund, M Schieber, Matthias Frick, Tetiana A Berezina, Tetiana A. Berezina

468

Publications

11.7K

Citations

H-Index

124

Concepts

All Affiliations

Paracelsus Medical University University of Cologne University of Salzburg Heinrich Heine University Düsseldorf Friedrich Schiller University Jena

About

Uta C. Hoppe is an author at Paracelsus Medical University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	46	4.1K
2	Public Health	13	16	1.6K
3	Health Sciences	3	3	410
4	Anesthesia	2	2	451
5	Social Sciences	1	1	48

Uta C. Hoppe

126

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, The Lancet Percutaneous Coronary InterventionControlled Syntax TrialEndovascular TechniqueCardiovascular DiseaseHealth Policy	2019	618
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension Felix Mahfoud, Markus P. Schlaich, Ingrid Kindermann, Circulation	2011	567
Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension Mathias C. Brandt, Felix Mahfoud, Sara Reda, Journal of the American College of Cardiology HypertensionUrologyResistant HypertensionBlood PressureCardiovascular Disease	2012	496
Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation Joachim Schöfer, Tomasz Siminiak, Michael Haude, Circulation	2009	363
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, The Lancet ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology	2022	296
Treatment of Functional Mitral Regurgitation by Percutaneous Annuloplasty: Results of the TITAN Trial Tomasz Siminiak, Justina Wu, Michael Haude, European Journal of Heart Failure	2012	287
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial Uta C. Hoppe, Mathias C. Brandt, Rolf Wachter, Journal of the American Society of Hypertension HypertensionHeart FailureInvasive SystemCardiovascular DiseaseAntihypertensive Therapy	2012	284
Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension Felix Mahfoud, Christian Ukena, Roland E. Schmieder, Circulation	2013	253
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure Uta C. Hoppe, Jaime M. Casares, Hans Eiskjær, Circulation	2006	204
First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension Michael Böhm, Felix Mahfoud, Christian Ukena, Hypertension	2015	188

Page 1